Tetrahydroisoquinolines derived from catecholamines or DOPA: effects on brain tyrosine hydroxylase activity.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D002395:Catecholamines / Q000096:biosynthesis / Q000494:pharmacology*; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D007980:Levodopa / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000378:metabolism; D051381:Rats; D012490:Salsoline Alkaloids / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002395:Catecholamines; D007546:Isoquinolines; D012490:Salsoline Alkaloids; D007980:Levodopa; D014446:Tyrosine 3-Monooxygenase